Apollo Medical (OTCMKTS:AMEH) released its quarterly earnings data on Wednesday. The healthcare company reported $0.24 EPS for the quarter, beating the Zacks’ consensus estimate of $0.09 by $0.15, Bloomberg Earnings reports. The firm had revenue of $167.28 million during the quarter.

AMEH opened at $22.60 on Friday. Apollo Medical has a 12 month low of $6.55 and a 12 month high of $30.00.

In related news, CEO Warren Hosseinion sold 22,900 shares of the company’s stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $15.94, for a total value of $365,026.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Adrian Vazquez sold 33,574 shares of the company’s stock in a transaction on Monday, September 10th. The shares were sold at an average price of $15.25, for a total transaction of $512,003.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 196,474 shares of company stock valued at $3,249,480.

An institutional investor recently bought a new position in Apollo Medical stock. Bank of New York Mellon Corp bought a new position in shares of Apollo Medical Holdings, Inc. (OTCMKTS:AMEH) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 61,450 shares of the healthcare company’s stock, valued at approximately $1,589,000. Bank of New York Mellon Corp owned approximately 0.18% of Apollo Medical at the end of the most recent quarter.

Separately, Zacks Investment Research upgraded shares of Apollo Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, October 16th.

COPYRIGHT VIOLATION WARNING: “Apollo Medical (AMEH) Posts Earnings Results, Beats Expectations By $0.15 EPS” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/11/16/apollo-medical-ameh-posts-earnings-results-beats-expectations-by-0-15-eps.html.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc is a patient-centered, physician-centric integrated population health management company working to provide coordinated, outcomes-based medical care. The Company operates in healthcare delivery segment. Its operations include Hospitalists, which include its contracted physicians focusing on the delivery of medical care to hospitalized patients; an accountable care organization (ACO), which focuses on providing care to Medicare fee-for-service patients; an independent practice association (IPA), which contracts with physicians and provides care to Medicare, Medicaid, commercial and dual-eligible patients on a risk- and value-based fee basis; approximately three clinics, which it owns or operates, and which provide specialty care in the greater Los Angeles area, and Palliative care, home health and hospice services, which include its at-home and end-of-life services.

Read More: Marijuana Stocks Future Looks Bright

Earnings History for Apollo Medical (OTCMKTS:AMEH)

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.